Spruce Biosciences, Inc. - SIC # 2836 - BIOLOGICAL PRODUCTS, EXCEPT DIAGNOSTIC SUBSTANCES

Ticker Exchange SIC # Website Latest Ticker
SPRB Nasdaq 2836 sprucebio.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Spruce Biosciences, Inc.

Spruce Biosciences Reports Second Quarter 2026 Financial Results and Provides Corporate Updates - Aug 12th, 2026 7:00 am
Cure Sanfilippo Foundation and National MPS Society Make $5.5 Million Strategic Investment in Spruce Biosciences - Aug 12th, 2026 6:00 am
Spruce Biosciences Appoints Jessica Cohen Pfeffer, M.D., as Vice President, Clinical Development - Aug 3rd, 2026 6:00 am
Spruce Biosciences Appoints Adrian Quartel, M.D., FFPM, as Chief Medical Officer - Jul 27th, 2026 6:00 am
American Express, Biogen upgraded: Wall Street's top analyst calls - Jul 13th, 2026 7:41 am
Spruce Biosciences to Participate in the B. Riley Securities 2026 Mind, Muscle & Vision Healthcare Summit - Jul 8th, 2026 2:01 pm
Spruce Biosciences Joins the Russell 3000® Index - Jun 29th, 2026 6:00 am
Spruce Biosciences Appoints Agnieszka Jurecka, M.D., Ph.D., MPH, as Vice President, Medical Affairs - Jun 22nd, 2026 6:00 am
Here Are Tuesday’s Best Wall Street Analyst Research Calls: Dynatrace, Emerson Electric, Exxon Mobil, Flutter Entertainment, Genuine Parts, nVent Electric, Palantir Technologies, Roku, and More - Jun 16th, 2026 5:52 am
Spruce Biosciences Appoints Eric Jordan as Vice President, Marketing and Tina Gullotta as Vice President, Finance and Corporate Controller - Jun 15th, 2026 6:00 am
Toll Brothers upgraded, Lennar downgraded: Wall Street's top analyst calls - Jun 9th, 2026 7:32 am
Spruce Biosciences Announces Long-Term Tralesinidase Alfa Enzyme Replacement Therapy Data in Sanfilippo Syndrome Type B (MPS IIIB) Presented at the 18th International MPS Symposium - Jun 8th, 2026 2:05 pm
Wall Street Analysts Believe Spruce Biosciences (SPRB) Could Rally 181.21%: Here's is How to Trade - Apr 3rd, 2026 7:55 am